4-Methylphenyl 2,3-di-O-benzyl-1-thio-β-D-glucopyranoside

Glycopharm.LLC was founded in Wuhan, China in April 2019. Our company has an outstanding research team engaged in the synthesis of sugar-based drug, e.g. glycolipids, glycopeptides, vaccines and so on. Our company’s mission was to provide solutions to the synthesis of all valuable sugar-based molecules in glycoscience. Our scientists are well educated to prepare sugar-based molecules in chemical and enzymatic way. Our company was equipped with very strict analytic instruments, e.g. HPLC, MS, NMR, to guarantee the high quality of each delivered product. We are trying our best to provide the highest quality of services and products and at the same time maintain very attractive prices to make sure that we are beneficial to your business development.